Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants

Pandemic influenza virus and SARS-CoV-2 vaiants have posed major global threats to public health. Broad-spectrum antivirals blocking viral entry can be an effective strategy for combating these viruses. Here, we demonstrate a frog-defensin-derived basic peptide (FBP), which broadly inhibits the infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hanjun, Meng, Xinjie, Peng, Zheng, Lam, Hoiyan, Zhang, Chuyuan, Zhou, Xinxin, Chan, Jasper Fuk-Woo, Kao, Richard Yi Tsun, To, Kelvin Kai-Wang, Yuen, Kwok-Yung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973381/
https://www.ncbi.nlm.nih.gov/pubmed/35259078
http://dx.doi.org/10.1080/22221751.2022.2051753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973381/
https://www.ncbi.nlm.nih.gov/pubmed/35259078
http://dx.doi.org/10.1080/22221751.2022.2051753

Ejemplares similares